Androgen receptor localization and turnover in human prostate epithelium treated with the antiandrogen, Casodex

Journal of Molecular Endocrinology

Volumn 24, Issue 3, 2000, Pages 339-351

  Waller, A S ^a   Sharrard, R M ^a   Berthon, P ^a   Maitland, N J ^a,b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Parc Scientifique de Luminy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; ANILIDE; ANTIANDROGEN;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; WESTERN BLOTTING; APOPTOSIS; ARTICLE; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROSTATE;

ANDROGEN ANTAGONISTS; ANILIDES; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; HUMANS; MALE; PROSTATE; RECEPTORS, ANDROGEN; TRANSFECTION;

EID: 0033625257     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0240339     Document Type: Conference Paper

References (46)

1. Berthon P, Cussenot O, Hopwood L, Le Duc A & Maitland N J 1995 Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: differentiation pattern of non-tumorigenic cell lines. International Journal of Oncology 6 333-343.
2. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G & Klocker H 1993a Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Molecular Endocrinology 7 1541-1550.
3. Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV & Bartsch G 1993b DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22 11-22.
4. Cussenot O, Berthon P, Faille A, Berger R, Mowszowicz I, Teillac P, LeDuc A & Calvo F 1991 Immortalization of human adult normal prostatic epithelial cells by liposomes containing SV40. Journal of Urology 143 881-886.
5. Dauvois S, Danielian PS, White R & Parker MG 1992 Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proceedings of the National Academy of Sciences of the USA 89 4037-4041.
6. Dauvois S, White R & Parker MG 1993 The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. Journal of Cell Science 106 1377-1388.
7. Elo JP, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O & Vihko P 1995 Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. Journal of Clinical Endocrinology and Metabolism 80 3494-3500.
8. Fawell SE, White R, Hoare S, Sydenham M, Page M & Parker MG 1990 Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proceedings of the National Academy of Sciences of the USA 87 6883-6887.
9. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW & Srivastava S 1994 Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Research 54 2861-2864.
10. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N & Narayan P 1995 Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cellular and Developmental Biology 31 14-24.
11. Isaacs JT, Furuya Y & Berges R 1994 The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Seminars in Cancer Biology 5 391-400.
12. Kallio PJ, Jänne OA & Palvimo JJ 1994 Agonists, but not antagonists, alter the conformation of the hormone-binding domain of androgen receptor. Endocrinology 134 998-1001.
13. Koivisto P, Kolmer M, Visakorpi T & Kallioniemi OP 1998 Androgen receptor gene and hormonal therapy failure of prostate cancer. American Journal of Pathology 152 1-9.
14. Kozak M 1989 The scanning model for translation; an update. Journal of Cell Biology 108 229-241.
15. Kuil CW & Mulder E 1994 Mechanism of antiandrogen action: conformational changes of the receptor. Molecular and Cellular Endocrinology 102 R1-R5.
16. Kuil CW & Mulder E 1995 Effects of androgens and antiandrogens on the conformation of the androgen receptor. Annals of the New York Academy of Sciences 761 351-354.
17. Kuil CW, Berrevoets CA & Mulder E 1995 Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization: studies on the mechanism of antiandrogen action. Journal of Biological Chemistry 270 27569-27576.
18. Kuiper GGJM & Brinkmann AO 1995 Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide. Biochemistry 34 1851-1857.
19. Laemmli EK 1970 The cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227 680-685.
20. McClelland RA, Gee JMW, Francis AB, Robertson JFR, Blamey RW, Wakelin, AE & Nicholson RI 1996 Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer. European Journal of Cancer 32A 413-416.
21. Marcelli M, Cunningham GR, Haidacher SJ, Padayatty SJ, Sturgis L, Kagan C & Denner L 1998 Caspase 7 is activated during lovastatin induced apoptosis of the prostate cancer cell line LNCaP. Cancer Research 58 76-83.
22. Montie JE 1996 A glimpse at the future of some endocrine aspects of prostate cancer. Prostate 6 57-61.
23. Pink JJ & Jordan VC 1996 Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Research 56 2321-2330.
24. Prostate Cancer Trialists' Collaborative Group 1996 Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients. Lancet 346 265-269.
25. Ruokonen M, Shan JD, Hedberg P, Patrikainen L & Vihko P 1996 Transfecting well-differentiated prostatic cancer cell line LNCaP. Biochemical and Biophysical Research Communications 218 794-796.
26. Saeed B, Zhang H & Ng S-C 1997 Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media. Prostate 31 145-152.
27. Schuurmans ALG, Bolt J, Veldscholte J & Mulder E 1991 Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. Journal of Steroid Biochemistry and Molecular Biology 40 193-197.
28. Sultan C, Lumbroso S, Poujol N, Belon C, Boudon C & Lobaccaro J-M 1993 Mutations of androgen receptor gene in androgen insensitivity syndromes. Journal of Steroid Biochemistry and Molecular Biology 46 519-530.
29. Suzuki H, Sato N, Watabe Y, Masai M, Seino S & Shimazaki J 1993 Androgen receptor gene mutations in human prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 46 759-765.
30. Taplin M-E, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN & Balk SP 1995 Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. New England Journal of Medicine 332 1393-1398.
31. Teutsch G, Goubet F, Battman T, Bonfils A, Bouchoux F, Cerede E, Gofflo D, Gaillard-Kelly M & Philibert D 1994 Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor. Journal of Steroid Biochemistry and Molecular Biology 48 111-119.
32. Tsuneoka M & Mekada E 1992 Degradation of a nuclear localised protein in mammalian COS cells using Escherichia coli 66 galactosidase as a model protein. Journal of Biological Chemistry 267 9107-9111.
33. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, Berrevoets C, Claasen E, van Rooij HCJ, Trapman J, Brinkmann AO & Mulder E 1990 A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and reponse to anti-androgens. Biochemical and Biophysical Research Communications 173 534-540.
34. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA & Mulder E 1992a Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31 2393-2399.
35. Veldscholte J, Berrevoets CA, Zegers ND, van der Kwast TH, Grootegoed JA & Mulder E 1992b Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry 31 7422-7430.
36. Veldscholte J, Berrevoets CA & Mulder E 1994 Studies on the human prostatic cancer cell line LNCaP. Journal of Steroid Biochemistry and Molecular Biology 49 341-346.
37. Vermes I, Haanen C, Steffensnakken H & Reutelingsperger C 1995 A novel assay for apoptosis - flow cytomeric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin V. Journal of Immunological Methods 184 39-51.
38. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J & Kallioniemi O-P 1995 in vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genetics 9 401-406.
39. Waller A 1998 The expression of androgen receptor protein in an in vitro model of prostate epithelial and stromal cells. DPhil Thesis. University of York.
40. Westin P, Bergh A & Damber J-E 1993 Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma. Prostate 22 65-74.
41. Westin P, Stattin P, Damber J-E & Bergh A 1995 Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. American Journal of Pathology 146 1368-1375.
42. 2-terminal and steroid-binding domains. Journal of Biological Chemistry 268 19004-19012.
43. 70, for the androgen receptor in human prostate cells. Proceedings of the National Academy of Sciences of the USA 93 5517-5521.
44. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu K & Keating A 1993 Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Research 53 1304-1311.
45. Zajchowski DA, Sager R & Webster L 1993 Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Research 53 5004-5011.
46. Zhou Z-X, Lane MV, Kemppainen JA, French FS & Wilson EM 1995 Specificity of ligand dependent androgen receptor stabilisation: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology 9 208-218.